Kukje Pharma국제약품
002720 · KOSPI · ₩002720 · 국제약품
₩3,345▼ ₩55 (1.62%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 53.7% | 53.4% | 52.7% | 49.7% | 50.0% | 45.5% |
| Operating margin | 2.5% | 3.5% | 4.3% | −1.5% | 4.2% | −1.4% |
| Net margin | 2.8% | 3.2% | 3.3% | −6.2% | 2.8% | −1.3% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +3.3% | +12.2% | +15.6% | +6.9% | +5.7% | — |
| Operating income growth | −27.6% | −7.7% | +436.9% | −137.7% | +414.6% | — |
| Net income growth | −12.2% | +9.5% | +161.9% | −336.6% | +328.2% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 5.1% | 6.1% | 6.0% | −10.6% | 5.0% | −2.3% |
| Return on assets | 2.7% | 3.3% | 3.2% | −5.6% | 2.6% | −1.1% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 86.4% | 86.6% | 84.9% | 92.2% | 84.4% | 103.8% |
| Net debt to equity | 12.2% | 16.7% | 22.6% | 22.8% | 28.9% | 38.0% |
| Current ratio | 113.9% | 108.6% | 199.6% | 92.3% | 101.4% | 88.4% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Kukje Pharma / 국제약품 / 002720 / KRX:002720
Source: KRX statistical information